Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Withdrawn 1Recruiting 1Completed 1

Sponsor Class

OTHER 3

Study Type

Observational 2Interventional 1

Sponsor

Cancer Type

Breast 4Other hematologic neoplasm 3Plasma cell 2Tumor-Agnostic 1NET 1Lymphoid 1Gynecologic 1Gastrointestinal 1Endocrine 1

Conditions

Hematologic Neoplasms 2Neoplasms, Plasma Cell 1Neoplasm Metastasis 1Lymphoma 1Leukemia 1

Interventions

Cytarabine 905Cyclophosphamide 899fludarabine 525venetoclax 489fludarabine phosphate 468Azacitidine 460Rituximab 431Methotrexate 419Etoposide 320Filgrastim 299Busulfan 296Dexamethasone 286Vincristine 285Daunorubicin 283Peripheral Blood Stem Cell Transplantation 258Whole-Body Irradiation 243Mycophenolic Acid 232Decitabine 230Granulocyte Colony-Stimulating Factor 227Tacrolimus 220Imatinib Mesylate 211Idarubicin 205Melphalan 202Cyclosporine 182Doxorubicin 177Radiotherapy 169Prednisone 164Dasatinib 163Mitoxantrone 161Lenalidomide 160

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Electronic Health Records × Other hematologic neoplasm × Clear all
NCT04888338 2026-04-16

Outcomes After Chimeric Antigen Receptor Therapy and Radiation Therapy for Hematologic Malignancies

M.D. Anderson Cancer Center

Recruiting
100 enrolled
Other hematologic neoplasm

Hematologic Neoplasms

NCT04820894 2025-05-23

Perception of Cure Among Patients With Metastatic Cancer

City of Hope Medical Center

Withdrawn
Other hematologic neoplasm

Neoplasm Metastasis, Hematologic Neoplasms

NCT02356549 2020-04-01

African American Cancer Clinical Trial Decisions: Testing Tailored Messages

Virginia Commonwealth University

Phase NA Completed
90 enrolled
LymphoidOther hematologic neoplasmPlasma cell

Leukemia, Lymphoma, Neoplasms, Plasma Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡